In [Table 2](#pone.0131384.t001){ref-type="table"}, the calendar year and the number of years are merged in the subheadings. Please view the correct [Table 2](#pone.0131384.t001){ref-type="table"} below.
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###### Patient outcomes at UHCMC and comparison with relevant studies describing 30-day mortality and relapse.
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  2.Study                                                         UHCMC 2008--2012 5 years   Levandovsky, et al. 1978--2002 24 years                       Kim, et al. 1998--2008 10 years   Lara, et al. 1978--1998 20 years                                         George, et al 1989--2003 14.5 years   Roberts, et al. 1984--1990 6 years
  --------------------------------------------------------------- -------------------------- ------------------------------------------------------------- --------------------------------- ------------------------------------------------------------------------ ------------------------------------- ------------------------------------
  Total cases (total cases used for mortality rate calculation)   59 (59)                    178 (167)^a^                                                  52 (52)                           126 (124)^c^                                                             290 (214)^e^                          14 (14)
   Idiopathic cause (%)                                           75                         72                                                            27                                71                                                                       39.3                                  43
   Secondary cause (%)                                            25                         28                                                            73                                29                                                                       60.7                                  57
   Age (mean\* or median\*\*)                                     49\*                       49\*                                                          47\*                              49\*                                                                     36\*\*^(f)^                           45\*
   Gender (Female, %)                                             70                         68                                                            61.5                              66                                                                       71                                    50%
  At presentation                                                                                                                                                                                                                                                                                           
   Hemoglobin (mg/dL) mean\* or median\*\*                        9\*                        9.2\*                                                         7.6\*\*                           8.9 \*                                                                   NS                                    9.8\*
   Serum creatinine (mg/dL) mean\* or median\*\*                  2.6\*                      3.2\*                                                         2.5\*\*                           3,4\*\*                                                                  1.2 \*\* ^f^                          5.7 ^g^
   Platelet (mean\* or median\*\*)                                46 x 10^9^/L\*             49 x 10^9^/L\*                                                30 x 10^9^/L\*\*                  44 x 10^9^/L\*                                                           11 x10^9^/L\*\* ^f^                   50 x 10^9^/L\*
   Clinical Severity Score (mean)                                 4\*                        4.4                                                           NS                                5                                                                        NS                                    NS
  Complete response (%)                                           81.2                       65                                                            51.9                              56                                                                       61^h^                                 NS
  30days-Relapse rate (%)                                         18.6                       18                                                            NS                                13                                                                       12                                    28.6
  TTP-HUS related deaths 30-days (number and %)                   4 (6.7%)                   23 (14%) ^b^                                                  18 (34.6%)                        12 (10%) ^d^                                                             38 (17%)                              1(7%)
  TPE as principal treatment (%)                                  100                        96                                                            100                               97                                                                       100                                   100
  Others principal treatment                                      N/A                        FFP infusion and Staphylococcal protein A absorption column   N/A                               FFP infusion Protein adsorption column therapy                           N/A                                   N/A
  Number of TPE procedures (mean\* or median\*\*)                 12\*                       8\*\*                                                         5\*\*                             NS                                                                       20 \*\* ^f^                           NS
  TPE-Technique used                                              COBE Spectra               NS                                                            COBE Spectra MFM (Plasauto)       Fenwal CS-3000 Blood Cell Separator Haemonetics model V50 Cobe Spectra   NS                                    NS
